BamSEC and AlphaSense Join Forces
Learn More

Werewolf Therapeutics Inc. – Indentures

NASDAQ: HOWL    
Share price (10/7/26): $0.92    
Market cap (10/7/26): $44.7 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 16 pages Form of Merger Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 17 pages Form of Pre-Funded Warrant to Purchase Common Stock
12/34/56
EX-4.6
from S-3 7 pages Form of Subordinated Note
12/34/56
EX-4.5
from S-3 7 pages Form of Senior Note
12/34/56
EX-4.4
from S-3 47 pages Werewolf Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.3
from S-3 45 pages Werewolf Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.1
from 10-Q 12 pages This Warrant and the Shares of Common Stock Issued Upon Its Exercise Are Subject to the Restrictions on Transfer Set Forth in Section 5 of This Warrant
12/34/56
EX-4.7
from S-3 7 pages Form of Subordinated Note
12/34/56
EX-4.6
from S-3 7 pages Form of Senior Note
12/34/56
EX-4.5
from S-3 47 pages Werewolf Therapeutics, Inc. and Trustee Indenture Dated as of Subordinated Debt Securities
12/34/56
EX-4.4
from S-3 45 pages Werewolf Therapeutics, Inc. and Trustee Indenture Dated as of Senior Debt Securities
12/34/56
EX-4.3
from 10-K 2 pages Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.2
from S-1 53 pages Werewolf Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement December 23, 2020
12/34/56
EX-4.2
from DRS 53 pages Werewolf Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement December 23, 2020
12/34/56